Medical versus surgical treatment in native hip and knee septic arthritis.


Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
03 2021
Historique:
received: 26 08 2019
revised: 07 01 2020
accepted: 28 04 2020
pubmed: 11 5 2020
medline: 15 9 2021
entrez: 11 5 2020
Statut: ppublish

Résumé

Antibiotic treatment and arthroscopic or open drainage is the gold standard for septic arthritis. Full recovery takes time after surgery and hospital stay is longer than for arthrocentesis at the bedside. We aimed to evaluate the effectiveness of arthrocentesis (medical approach) versus a surgical approach. We retrospectively included 97 cases of native joint arthritis (hip and knee) between 2010 and 2017. The primary outcome was treatment failure of medical and surgical approaches (defined as surgical intervention within 7 days following diagnosis). Risk factors of failure were identified by univariable and multivariable logistic regression. We included 72 cases of knee arthritis, of which 43 and 29 were treated medically and surgically, respectively; 25 cases of hip arthritis, of which 8 and 17 were treated medically and surgically, respectively. Failure was observed in 39.2% of cases in the medical group and in 30.4% in the surgical group (P=0.2) (37.5% vs. 52.9% and 39.5% vs. 17.2% for hip and knee, respectively). The univariate analysis identified age and male sex as risk factors for failure (P=0.048 and P=0.02, respectively), but only age was independently associated with failure (P=0.04). Hospital length of stay was 12 days shorter in the medical group (21 vs. 33 days, P=0.02), sequelae were less frequent and less important in the medical group (31.7% vs. 60%). The medical treatment seems to be as effective as the surgical treatment for native joint septic arthritis with a shorter hospital stay and better functional outcome. Further prospective studies are warranted.

Identifiants

pubmed: 32387296
pii: S0399-077X(20)30125-6
doi: 10.1016/j.medmal.2020.04.019
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-169

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

C Mabille (C)

Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France. Electronic address: mabille.camille@chu-amiens.fr.

Y El Samad (Y)

Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France.

C Joseph (C)

Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France.

B Brunschweiler (B)

Department of Orthopedic surgery, University Hospital of Amiens-Picardie, Amiens, France.

V Goeb (V)

Department of Rheumatology, University Hospital of Amiens-Picardie, Amiens, France.

F Grados (F)

Department of Rheumatology, University Hospital of Amiens-Picardie, Amiens, France.

J P Lanoix (JP)

Department of Infectious Diseases, University Hospital of Amiens-Picardie, Amiens, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH